Stock Scorecard
Stock Summary for Transmedics Group Inc (TMDX) - $68.58 as of 3/28/2025 9:10:04 PM EST
Total Score
8 out of 30
Safety Score
47 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TMDX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TMDX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TMDX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TMDX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TMDX (47 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 6 |
| Stock Price Trend (Max of 10) | 10 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TMDX
Financial Details for TMDX
Company Overview |
|
|---|---|
| Ticker | TMDX |
| Company Name | Transmedics Group Inc |
| Country | USA |
| Description | TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 4/28/2025 |
Stock Price History |
|
| Last Day Price | 68.58 |
| Price 4 Years Ago | 19.16 |
| Last Day Price Updated | 3/28/2025 9:10:04 PM EST |
| Last Day Volume | 611,572 |
| Average Daily Volume | 1,165,571 |
| 52-Week High | 177.37 |
| 52-Week Low | 55.00 |
| Last Price to 52 Week Low | 24.69% |
Valuation Measures |
|
| Trailing PE | 65.83 |
| Industry PE | 25.03 |
| Sector PE | 40.10 |
| 5-Year Average PE | -23.73 |
| Free Cash Flow Ratio | 6.99 |
| Industry Free Cash Flow Ratio | 16.96 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 8.20 |
| Total Cash Per Share | 9.81 |
| Book Value Per Share Most Recent Quarter | 6.80 |
| Price to Book Ratio | 10.35 |
| Industry Price to Book Ratio | 3.00 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 5.37 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.90 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 33,662,400 |
| Market Capitalization | 2,308,567,392 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 76.90% |
| Annual Earnings Growth | 30.92% |
| Reported EPS 12 Trailing Months | 1.07 |
| Reported EPS Past Year | 1.01 |
| Reported EPS Prior Year | -0.77 |
| Net Income Twelve Trailing Months | 32,638,000 |
| Net Income Past Year | -25,028,000 |
| Net Income Prior Year | -36,231,000 |
| Quarterly Revenue Growth YOY | 49.80% |
| 5-Year Revenue Growth | 78.87% |
| Operating Margin Twelve Trailing Months | 7.11% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 330,094,000 |
| Total Cash Past Year | 394,812,000 |
| Total Cash Prior Year | 201,182,000 |
| Net Cash Position Most Recent Quarter | -178,437,000 |
| Net Cash Position Past Year | -111,392,000 |
| Long Term Debt Past Year | 506,204,000 |
| Long Term Debt Prior Year | 58,696,000 |
| Total Debt Most Recent Quarter | 508,531,000 |
| Equity to Debt Ratio Past Year | 0.21 |
| Equity to Debt Ratio Most Recent Quarter | 0.29 |
| Total Stockholder Equity Past Year | 137,202,000 |
| Total Stockholder Equity Prior Year | 187,375,000 |
| Total Stockholder Equity Most Recent Quarter | 209,920,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -120,512,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -3.58 |
| Free Cash Flow Past Year | -164,875,000 |
| Free Cash Flow Prior Year | -57,724,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.58 |
| MACD Signal | -0.54 |
| 20-Day Bollinger Lower Band | 54.89 |
| 20-Day Bollinger Middle Band | 70.29 |
| 20-Day Bollinger Upper Band | 85.69 |
| Beta | 2.12 |
| RSI | 51.17 |
| 50-Day SMA | 111.25 |
| 150-Day SMA | 78.49 |
| 200-Day SMA | 65.10 |
System |
|
| Modified | 3/28/2025 9:18:05 AM EST |